Substances and agents with claimed antiviral or related therapeutic activity are indexed below. Most of these are drugs or other substances which directly affect target viruses. Additional therapeutic agents can be found in the Vaccine and Immune Modulator Indexes below.
__________
1,4-diamine-2,3-dihydroxybutanes - Apr., 5,294,720
1,5-dideoxy-1,5-imino-D-glucitol deriv. - May, 5,310,745
2-formylbenzylphosphonic acid deriv. - Feb., 5,278,152
2'-alkylidenepyrimidine nucleosides - May, 5,300,636
2',3'-dideoxyadenosine - Mar., 5,290,927
4-aminoquinoline - Feb., 5,278,173
acemannan - May, 5,308,838
acridine deriv. - Sep., 5,342,752
acyclovir - Sep., 5,336,770
acyl-carnitine - June, 5,314,689
aliphatic dialdehyde- Sep., 5,344,838
alkali metal fatty acid salt - Jan. 95, 5,370,876
alpha 1-antitrypsin - Jan. 95, 5,376,633
amantadine - Mar., 5,290,686
amine oxides - June, 5,314,917
aminopyridones - May, 5,308,854
anti-inflammatory agent - Mar., 5,290,540
antigen/anti-immunoglobulin antibody conjugates - Feb., 5,283,323
antisense oligonucleotides - Feb., 5,278,051; 5,278,302; Mar., 5,286,717; Apr., 5,292,875; Nov., 5,359,044
arabinogalactan-iron complexes - Aug., 5,336,506
aromatic polycyclic diones - July, 5,326,788
ascorbic acid - Jan. 95, 5,371,107
asialoglycoprotein-drug conjugates - Oct., 5,346,696
azido-fatty acid analogs - Sep., 5,338,858
benzenes, phenoxy-methyl-phenyl-methoxy- - Oct., 5,350,772
benzimidazoles, deoxyribofuranosyl- - Dec., 5,360,795
benzodiazepin-2-(thi)ones, tetrahydroimidazo(1,4)- - Jan. 95, 5,371,079
benzothiadiazine 1-oxide, 3,4-dihydro-1-phenyl-3-thio-1,2,4- - July, 5,321,024
betaine deriv. - June, 5,314,917
bile powder - May, 5,302,391
bis-hexahydropyrimidinylalkyl deriv. - Sep., 5,342,945
BU-3889V - Mar., 5,286,649
camptothecins - July, 5,321,140; Dec., 5,364,858
carbolines, N-oxo-tetrahydro-beta- - Oct., 5,348,949
carboxamides, benzo(b)thiophene-2- - Oct., 5,350,748
catalytic antibodies - July, 5,318,897
cationic lipids - Feb., 5,283,185
CD4 - Feb., 5,278,050
chlorhexidine - Aug., 5,334,588
cholinesterase inhibitors - June, 5,312,817
cinnamic acid, p-hydroxylated deriv. - Oct., 5,346,695
crown ether polysaccharides - June, 5,314,878
cycloalkyimidazopyridin-4-amines - Nov., 5,352,784
cyclobutane deriv. - July, 5,324,730
cyclobutane nucleosides - May, 5,306,837; Oct., 5,344,962; Dec., 5,369,098
cyclobutyl oligonucleotides - Nov., 5,359,044
cyclocreatine - July, 5,321,030; 5,324,731
cyclopentyladenine, 9-(1R,2R,3S)-2,3-bis(hydroxymethyl)- - Jan. 95, 5,374,625
cyclopropane nucleosides - Sep., 5,342,840
DAP 30 and DAP 32 - June, 5,317,009
deoxynojirimycin deriv. - Aug., 5,331,096; Sep., 5,342,951; Oct., 5,350,854
detergent - Aug., 5,333,626
Dianthus caryophyllus - June, 5,317,009
diazepines, 5,11-dihydro-6H-dipyrido(3,2-b:2',3'-e)(1,4)- - Dec., 5,366,972
didemnin A deriv. - Apr., 5,294,603
diketopiperazine microparticles - Oct., 5,352,461
dinucleoside polyphosphate - May, 5,306,629
diols, pentane/hexane - Dec., 5,369,129
diphtheria toxin A - May, 5,306,631
enediyne dihydroperoxides - Mar., 5,288,761
epoxyhex-5-en-1-ol - Apr., 5,296,620
Eriobotrya japonica - Feb., 5,279,827
ethanol - Apr., 5,298,222
ethyl alcohol - Aug., 5,331,012
ethylene oxide - June, 5,314,682
ferritin - Feb., 5,283,177
fibroblast growth factor - Mar., 5,288,704
filters - Dec., 5,368,920
fluoronucleosides, 2'-deoxy-2',2'-fluorinated - Jan. 95, 5,371,210
fluorothymidine, 2',3'-dideoxy-3'- - Jan. 95, 5,376,644
galanthamine deriv. - June, 5,312,817
gamma radiation - Dec., 5,362,442
ganciclovir - Sep., 5,336,770
GAP 31 - June, 5,317,009
garlic - May, 5,302,391
gastrointestinal delivery - Nov., 5,358,721
Gelonium multiflorum - June, 5,317,009
gels, drug delivery - Oct., 5,346,703
gloves, antiseptic - Aug., 5,335,373; Nov., 5,357,636
glutaraldehyde - July, 5,322,856
glycerol, 1,2-isopropylidene- - Aug., 5,332,674
glycyrrhetinic acid deriv. - Nov., 5,356,880
guanidinoacetate - July, 5,324,731
guanidinobenzene deriv. - Nov., 5,352,704
guanine, 9(2-(phosphonomethoxy)propyl)- - May, 5,302,585
hapten-solid support complexes - Feb., 5,283,066
heat-treated hemoglobin - Feb., 5,281,579
heptafluoropropane - June, 5,314,682
herpes simplex virus UL13 - Aug., 5,334,498
histidine, L- - Oct., 5,352,691
HIV art (rev) protein - July, 5,321,124
HIV peptides - Oct., 5,346,989
homocyclocreatine - July, 5,324,731
hydrocarbon peroxide deriv. - Dec., 5,364,879
hyperthermia, whole body - Nov., 5,354,277
imexon - Dec., 5,369,119
imidazole deriv. - July, 5,326,780
imidazole-4-ethanamine, phosphate - Apr., 5,294,440
influenza A M2 protein - Mar., 5,290,686
inosine, 2',3'-dideoxy (ddI) - Jan. 95, 5,376,642
interleukin-2/antibody fusion proteins - Oct., 5,349,053
iodinated resin - Dec., 5,370,534
iodine, controlled-release - Sep., 5,344,411
kappa-casein - Sep., 5,344,820
KU 10,001 - June, 5,316,775; Aug., 5,334,395
kukui nut - Feb., 5,286,488
Lentinus edodes - Feb., 5,283,239
leukoregulin - Dec., 5,368,853
licorice - May, 5,302,391
lidocaine - Mar., 5,290,686
lipoproteins, oxidized - Dec., 5,366,440
liposomal adjuvants - June, 5,312,620
liposomes - Feb., 5,279,833; Aug., 5,330,689; Sep., 5,340,588
liver extracts - June, 5,316,775; Aug., 5,334,395
magnetic fields - Dec., 5,366,435
MCA 86 monoclonal antibody - Apr., 5,298,419
methionine deriv. - Mar., 5,292,773
microcapsules - Feb., 5,286,495
Mirabilis antiviral protein - July, 5,318,900; Sep., 5,340,732
muramyldipeptide deriv. - Mar., 5,292,506; Jan. 95, 5,376,369
N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-alanine-2-(1,2-dipalmitoyl-sn-glycero3-hydroxyphosphoryloxy)-ethylamide - Aug., 5,334,583
naltrexone - Nov., 5,356,900
naphthoquinone deriv. - June, 5,314,914
neem extracts - Jan. 95, 5,370,873
neuraminic acid, 2-deoxy-2,3-didehydro-N-acetyl deriv. - Dec., 5,360,817
nonapeptide - Oct., 5,352,665
nucleoside deriv. - June, 5,310,895
nucleosides, 2'-fluoro- - Aug., 5,336,764
nucleosides, 5'-alkylphosphonyl- - Jan. 95, 5,374,626
nucleosides, acyclic side chain - July, 5,318,974
nucleosides, acyclic - Sep., 5,336,770
nucleosides, glycosylphospholipid - Nov., 5,358,937
nucleosides, hydroxymethyl(methylenecyclopentyl)- - Sep., 5,340,816
oligonucleotides - July, 5,319,080
opiate receptor antagonists - Nov., 5,356,900
oxetanocin, 2-halogeno- - Feb., 5,283,331
oxidizing agents - Feb., 5,281,392
oxygen radical scavenger - Feb., 5,283,034
oxygermylpropionic acid polymers - Sep., 5,340,806
parabactin - Mar., 5,292,775
pendulan - July, 5,320,849
pentamidine - Dec., 5,364,615
peptides - Apr., 5,298,490
phagocytosable particles - Mar., 5,292,513
phenoxyalkylisoazoles, 1,2,4-oxadiazolyl- - Oct., 5,349,068
phospholipids - Mar., 5,286,719
photodynamic agents - May, 5,304,113; Dec., 5,360,734
photosensitizers - Sep., 5,342,752; Dec., 5,369,101
Phytolacca insularis antiviral protein - Oct., 5,348,865
piperidines, phenoxy- deriv. - Dec., 5,364,865
podophyllotoxin - June, 5,315,016; Aug., 5,336,605
poly I:poly(cytidylate/4-thiouridylate) - Apr., 5,298,614
polystyrenesulfonate - May, 5,308,612
POP-POE block polymers - Jan. 95, 5,376,369
porphyrin deriv. - Feb., 5,281,616; 5,283,255; May, 5,308,608; Dec., 5,369,101
potassium nitrate - Oct., 5,348,981
pseudopeptides, phosphonate-containing - Dec., 5,364,931
purine deriv. - Aug., 5,332,814; Nov., 5,356,886
pyridazinamines - Mar., 5,292,738
pyrimidine nucleosides - July, 5,318,972
pyrimidine, 1-carboxymethyl-2-iminohexahydro- - July, 5,324,731
pyrimidines, 6-pyridyl - Feb., 5,278,167
pyrimidines, N-5-protected 2,5-diamino-4,6-dichloro- - Apr., 5,294,710
pyrimidinones/pyrimidinediones - June, 5,314,893
pyrroles/pyrrolidines - Feb., 5,278,184
quaternary ammonium compounds - Sep., 5,338,748; 5,344,838
quillaja - May, 5,302,391
quinolin-4-amines, 1H-imidazo(4,5-c)- - Oct., 5,346,905
quinolines,4-((alkyl or dialkyl)amino)- - May, 5,304,554
quinolone metal complexes - May, 5,304,559
quinolone-carboxylic acids - May, 5,300,643
reverse transcriptase inhibitors - Sep., 5,344,774
ribonucleoside phosphoramidites - Feb., 5,281,701
ribozymes - Apr., 5,298,612; Aug., 5,334,711; Nov., 5,354,855; 5,359,051
rubella virus E1 and C proteins - Apr., 5,298,596
Salphurbon Lotion - Oct., 5,348,981
schizophyllan - July, 5,320,849
scleroglucan - July, 5,320,849
silver acyclic polyether polymers - July, 5,326,567
silver sulfadiazine - Aug., 5,334,588
sodium deoxycholate - Aug., 5,334,588
sodium thiocyanate - May, 5,300,433
soy protein hydrolysate - Aug., 5,330,972
stilbenes, sulfonic acid deriv. - Dec., 5,359,131
sulfated polysaccharides - Mar., 5,288,704
sulfonic acid deriv. - June, 5,312,837
sulfur - Oct., 5,348,981
sulphated polyvinyls - Mar., 5,292,505
sulphur carboxylic acid deriv. - Aug., 5,334,612
surfactants - Jan. 95, 5,371,196
T-cell proteins - Oct., 5,346,988
tetra-polyols - Jan. 95, 5,376,369
tetrasilver tetroxide - Aug., 5,336,499
texaphyrin - Dec., 5,369,101
thionucleosides, pyrimidine 4'- - Nov., 5,356,882
thymidine derivatives - May, 5,306,722
thymosin alpha 1 - May, 5,308,833
tocopheryl oligosaccharides - Feb., 5,280,111
toluenesulfonyloxypropane, (RS)-1-fluoro-2-phosphonomethoxy-3-p- - Nov., 5,352,786
tri-n-butyl phosphate - Jan. 95, 5,371,196
trimethylenebis(1,3-dioxolane) - Aug., 5,334,615
tripyrrole dimethine deriv. - Dec., 5,369,101
TRP-185 cellular protein - Oct., 5,350,835
uracil, (E)-5-(2-bromovinyl)arabinofuranosyl- - Nov., 5,352,584
ureas - June, 5,312,831
urethanes - June, 5,312,831
vectors - Dec., 5,364,773